Fucoidan from Fucus vesiculosus Protects against Alcohol-Induced Liver Damage by Modulating Inflammatory Mediators in Mice and HepG2 Cells
Jung Dae Lim,Sung Ryul Lee,Taeseong Kim,Seon-A Jang,Chan Kang,Hyun Jung Koo,Eunsoo Sohn,Jong Phil Bak,Seung Namkoong,Hyoung Kyu Kim,In Sung Song,Nari Kim,Eun-Hwa Sohn,Jin Han,Jung Lim,Sung Lee,Se Kang,Hyun Koo,Jong Bak,Hyoung Kim,In Song
DOI: https://doi.org/10.3390/md13021051
2015-02-16
Marine Drugs
Abstract:Fucoidan is an l-fucose-enriched sulfated polysaccharide isolated from brown algae and marine invertebrates. In this study, we investigated the protective effect of fucoidan from Fucus vesiculosus on alcohol-induced murine liver damage. Liver injury was induced by oral administration of 25% alcohol with or without fucoidan (30 mg/kg or 60 mg/kg) for seven days. Alcohol administration increased serum aspartate aminotransferase and alanine aminotransferase levels, but these increases were suppressed by the treatment of fucoidan. Transforming growth factor beta 1 (TGF-β1), a liver fibrosis-inducing factor, was highly expressed in the alcohol-fed group and human hepatoma HepG2 cell; however, the increase in TGF-β1 expression was reduced following fucoidan administration. Treatment with fucoidan was also found to significantly reduce the production of inflammation-promoting cyclooygenase-2 and nitric oxide, while markedly increasing the expression of the hepatoprotective enzyme, hemeoxygenase-1, on murine liver and HepG2 cells. Taken together, the antifibrotic and anti-inflammatory effects of fucoidan on alcohol-induced liver damage may provide valuable insights into developing new therapeutics or interventions.
pharmacology & pharmacy,chemistry, medicinal